Previous Exposure to Multiple Anti-TNF Is Associated with Decreased Efficiency in Preventing Postoperative Crohn's Disease Recurrence. (Q51541150)

6 April 2018

title

Previous Exposure to Multiple Anti-TNF Is Associated with Decreased Efficiency in Preventing Postoperative Crohn's Disease Recurrence. (English)

1 reference

6 April 2018

0 references

1 reference

Laurent Peyrin-Biroulet

12

Laurent Peyrin-Biroulet

1 reference

6 April 2018

Maria Nachury

6

0 references

Philippe Zerbib

Philippe Zerbib

8

0 references

Antoine Cortot

Antoine Cortot

7

0 references

Pierre Desreumaux

Pierre Desreumaux

10

0 references

Jean-Frédéric Colombel

11

Jean-Frédéric Colombel

1 reference

6 April 2018

Corinne Gower-Rousseau

3

Corinne Gower-Rousseau

1 reference

6 April 2018

Guillaume Pineton de Chambrun

13

Guillaume Pineton de Chambrun

1 reference

6 April 2018

Hélène Sarter

2

Hélène Sarter

1 reference

6 April 2018

Dine Koriche

4

Dine Koriche

1 reference

6 April 2018

Louise Libier

5

Louise Libier

1 reference

6 April 2018

author name string

Michael Collins

1

1 reference

6 April 2018

Pierre Blanc

9

1 reference

6 April 2018

publication date

30 August 2016

1 reference

6 April 2018

Journal of Crohn's and Colitis

published in

1 reference

6 April 2018

volume

11

1 reference

6 April 2018

issue

3

1 reference

6 April 2018

page(s)

281-288

1 reference

6 April 2018

Hospitalisations and surgery in Crohn's disease

cites work

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW151

Review article: the natural history of postoperative Crohn's disease recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW151

Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW151

Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW151

Faecal diversion for Crohn's colitis: a model to study the role of the faecal stream in the inflammatory process

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW151

Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW151

The effect of smoking after surgery for Crohn's disease: a meta-analysis of observational studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW151

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW151

Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW151

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW151

Prevention and treatment of postoperative Crohn's disease recurrence with anti-TNF therapy: a meta-analysis of controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW151

Crohn's disease management after intestinal resection: a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW151

Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW151

Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW151

Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection: a 3-year prospective randomized open trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW151

Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of postoperative recurrence of Crohn's disease: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW151

Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW151

Distinct profiles of effector cytokines mark the different phases of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW151

Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW151

Identification of inflammatory mediators in patients with Crohn's disease unresponsive to anti-TNFα therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW151

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW151

Infliximab prevents Crohn's disease recurrence after ileal resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FECCO-JCC%2FJJW151

21 January 2018

Identifiers

DOI

10.1093/ECCO-JCC/JJW151

1 reference

6 April 2018

1 reference

6 April 2018